Publications

Renal fibrosis is the central pathogenic process in progression of chronic kidney disease (CKD). Collagen type VI (COL VI) is upregulated in renal fibrosis. Endotrophin is released from COL VI and promotes pleiotropic pro-fibrotic effects. Kidney disease severity varies considerably and accurate inf...

Read the publication

• Renal Diseases
• Chronic Kidney Disease
• Fibrosis

Background: The extent of renal fibrosis in chronic kidney disease (CKD) is the best predictor for progression of most renal diseases. To date, no established biomarkers of renal fibrosis exist. Methods: We measured circulating and urinary-specific matrix metalloproteinase (MMP)-generated collagen ...

Read the publication

• Renal Diseases
• Chronic Kidney Disease
• Fibrosis

Background: Renal fibrosis is the hallmark of progression to end-stage kidney disease. Non-invasive biomarkers of renal fibrosis could serve as specific end points in clinical trials and improve monitoring and stratification of patients with chronic kidney disease (CKD). To address this, we measured...

Read the publication

• Renal Diseases
• Glomerular Diseases
• IgA Nephropathy
• Fibrosis

Interstitial fibrosis is the common endpoint of end-stage chronic kidney disease (CKD) leading to kidney failure. The clinical course of many renal diseases, and thereby of CKD, is highly variable. One of the major challenges in deciding which treatment approach is best suited for a patient but also...

Read the publication

• Renal diseases
• Chronic Kidney Disease
• Fibrosis